Document Detail


Does the use of paclitaxel or rapamycin-eluting stent decrease further need for coronary-artery bypass grafting when compared with bare-metal stent?
MedLine Citation:
PMID:  17992397     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT AND OBJECTIVE: The safety and efficacy of drug-eluting stents reduce the need for surgical revascularization. The objective of the present study was to investigate whether paclitaxel or rapamycin-eluting stent are effective in avoiding the need for coronary-artery bypass grafting. METHODS: This was a systematic review of the literature using the methodology of the Cochrane Collaboration. The type of study considered was controlled randomized trials; the type of intervention was drug-eluting or bare-metal stents; and the main outcome investigated was coronary-artery bypass grafting. RESULTS: The ten studies included in this systematic review did not show any statistically significant difference between the drug-eluting stents and the bare-metal stents with regard to the outcome of coronary-artery bypass grafting (confidence interval: 0.31 to 1.42). CONCLUSION: The surgical revascularization rate was not reduced by the use of drug-eluting stents.
Authors:
Hernani Pinto de Lemos Jr; Alvaro Nagib Atallah
Related Documents :
12062617 - Acute vasculitis after endovascular brachytherapy.
11428537 - Time course of vascular remodeling, formation of neointima and formation of neoadventit...
17187467 - Xience v everolimus-eluting coronary stent system: a novel second generation drug-eluti...
18804877 - Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional in...
18619777 - Outcomes of amplatzer vascular plugs for occlusion of internal iliacs during aortoiliac...
10385217 - Effects of nicardipine on collar-induced intimal thickening and vascular reactivity in ...
Publication Detail:
Type:  Comparative Study; Journal Article; Meta-Analysis; Review    
Journal Detail:
Title:  São Paulo medical journal = Revista paulista de medicina     Volume:  125     ISSN:  1516-3180     ISO Abbreviation:  Sao Paulo Med J     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-11-09     Completed Date:  2008-09-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897261     Medline TA:  Sao Paulo Med J     Country:  Brazil    
Other Details:
Languages:  eng     Pagination:  242-5     Citation Subset:  IM    
Affiliation:
Brazilian Cochrane Center, Universidade Federal de São Paulo-Escola Paulista de Medicina, São Paulo, Brazil. cochrane.dmed@epm.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Artery Bypass*
Coronary Restenosis / prevention & control*
Cytostatic Agents / administration & dosage*
Drug-Eluting Stents
Humans
Paclitaxel / administration & dosage*
Randomized Controlled Trials as Topic
Sirolimus / administration & dosage*
Stents*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Cytostatic Agents; 33069-62-4/Paclitaxel; 53123-88-9/Sirolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial.
Next Document:  Karyotype abnormalities and their clinical significance in a group of chronic myeloid leukemia patie...